Solventum Corp
SOLVAPI behind this page
SOLV Q3 2025 request
Playground key active
/api/financials?ticker=SOLV&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 2,096 | 2,082 | +0.7% |
Show Product Lines breakouts |
|||
| Cost of software and rentals | 502 | 474 | +5.9% |
| Product | 1,594 | 1,608 | -0.9% |
| Product · After Spin-Off | 22 | 17 | +29.4% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 340 | 313 | +8.6% |
| Health Information Systems · Operating Segments | 345 | 326 | +5.8% |
| MedSurg · Advanced Wound Care | 485 | 468 | +3.6% |
| MedSurg · Infection Prevention and Surgical Solutions | 722 | 713 | +1.3% |
| MedSurg · Operating Segments | 1,206 | 1,182 | +2.0% |
| Purification and Filtration · Operating Segments | 128 | 180 | -28.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 77 | 81 | -4.9% |
| Operating Segments | 1,891 | 1,821 | +3.8% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 22 | 17 | +29.4% |
| Cost of Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Cost of software and rentals | 114 | 124 | -8.1% |
| Product | 847 | 793 | +6.8% |
| Product · After Spin-Off | 167 | 171 | -2.3% |
Show Related Party Transaction breakouts |
|||
| Master Supply Agreements · Related Party | 64 | 68 | -5.9% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 17 | 12 | +41.7% |
| Gross Profit | 1,135 | 1,165 | -2.6% |
| Selling, General & Administrative | 780 | 701 | +11.3% |
Show Related Party Transaction breakouts |
|||
| After Spin-Off · Related Party | 67 | 63 | +6.3% |
| Research & Development | 183 | 189 | -3.2% |
Show Related Party Transaction breakouts |
|||
| After Spin-Off · Related Party | 2 | 2 | 0.0% |
| Gain Loss On Sale Of Business | -1,518 | — | — |
| Operating Income | 1,690 | 275 | +514.5% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 87 | 74 | +17.6% |
| Health Information Systems · Operating Segments | 134 | 105 | +27.6% |
| MedSurg · Operating Segments | 203 | 243 | -16.5% |
| Purification and Filtration · Operating Segments | 26 | 19 | +36.8% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 12 | 5 | +140.0% |
| Operating Segments | 424 | 422 | +0.5% |
| Interest Income Expense Nonoperating Net | 89 | 107 | -16.8% |
| Gains Losses On Extinguishment Of Debt | 82 | — | — |
| Other Non-Operating Income (Expense) | 5 | 1 | +400.0% |
| Income Before Taxes | 1,514 | 167 | +806.6% |
| Income Tax Expense (Benefit) | 248 | 45 | +451.1% |
| Net Income | 1,266 | 122 | +937.7% |
Show Equity Components breakouts |
|||
| Retained Earnings | 1,266 | 122 | +937.7% |
| EPS (Basic) | 7.26 | 0.7 | +937.1% |
| EPS (Diluted) | 7.22 | 0.7 | +931.4% |
| Wtd Avg Shares (Basic) | 174.3 | 173.4 | +0.5% |
| Wtd Avg Shares (Diluted) | 175.4 | 173.9 | +0.9% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 118 | 109 | +8.3% |
| Health Information Systems · Operating Segments | 80 | 92 | -13.0% |
| MedSurg · Operating Segments | 599 | 539 | +11.1% |
| Total Costs & Expenses (Q) | — | — | — |
Show Related Party Transaction breakouts |
|||
| Transition Agreement Services · Related Party | 145 | 144 | +0.7% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 134 | 130 | +3.1% |
| Health Information Systems · Operating Segments | 131 | 129 | +1.6% |
| MedSurg · Operating Segments | 405 | 399 | +1.5% |
| Comprehensive Income | 1,293 | 300 | +331.0% |
| Other Comprehensive Income | 27 | 178 | -84.8% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 44 | 10 | +340.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 7 | -11 | +163.6% |
| Accumulated Other Comprehensive Income | 27 | 178 | -84.8% |
| Accumulated Translation Adjustment | -24 | 179 | -113.4% |
| Operating Lease Lease Income | 157 | 148 | +6.1% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,642 | — | — |
| Accounts Receivable | 1,019 | — | — |
| Other Receivables Net Current | 157 | — | — |
| Inventory Finished Goods Net Of Reserves | 625 | — | — |
| Inventory Work In Process Net Of Reserves | 191 | — | — |
| Inventory Raw Materials And Supplies Net Of Reserves | 233 | — | — |
| Inventory | 1,049 | — | — |
| Other Assets Current | 540 | — | — |
| Total Current Assets | 4,407 | — | — |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,336 | — | — |
| Goodwill | 5,260 | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 477 | — | — |
| Health Information Systems · Operating Segments | 875 | — | — |
| MedSurg · Operating Segments | 3,800 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 108 | — | — |
| Other Non-Current Assets | 747 | — | — |
| Total Assets | 13,973 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 2,223 | — | — |
| Current Liabilities | |||
| Accounts Payable | 669 | — | — |
| Accrued Liabilities | 464 | — | — |
| Deferred Revenue (Current) | 576 | — | — |
| Other Liabilities Current | 1,229 | — | — |
| Total Current Liabilities | 2,938 | — | — |
| Non-Current Liabilities | |||
| Long-Term Debt | 5,137 | — | — |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 306 | — | — |
| Deferred Tax Liabilities | 169 | — | — |
| Other Non-Current Liabilities | 437 | — | — |
| Total Liabilities | 8,987 | — | — |
| Long-Term Debt | 5,137 | 8,109,000,000 | -100.0% |
Show Debt Instrument breakouts |
|||
| 5.40% Senior Notes Due 2029 · Senior Notes | 698 | 1,487,000,000 | -100.0% |
| 5.45% Senior Notes Due 2027 · Senior Notes | 349 | 994,000,000 | -100.0% |
| 5.45% Senior Notes Due 2031 · Senior Notes | 991 | 990,000,000 | -100.0% |
| 5.60% Senior Notes Due 2034 · Senior Notes | 1,637 | 1,636,000,000 | -100.0% |
| 5.90% Senior Notes Due 2054 · Senior Notes | 1,210 | 1,231,000,000 | -100.0% |
| 6.00% Senior Notes Due 2064 · Senior Notes | 42 | 492,000,000 | -100.0% |
| Credit Facilities · Three year senior term loan credit facility | 210 | 979,000,000 | -100.0% |
| Stockholders' Equity | |||
| Common Stock | 2 | — | — |
| Additional Paid-In Capital | 3,854 | — | — |
| Retained Earnings | 1,734 | — | — |
| Accumulated Other Comprehensive Income | -604 | — | — |
| Total Stockholders' Equity | 4,986 | 3,192 | +56.2% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -456 | -502 | +9.2% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -12 | -10 | -20.0% |
| Accumulated Other Comprehensive Income | -604 | -765 | +21.0% |
| Accumulated Translation Adjustment | -136 | -253 | +46.2% |
| Additional Paid In Capital | 3,854 | 3,744 | +2.9% |
| Common Stock | 2 | 2 | 0.0% |
| Retained Earnings | 1,734 | 211 | +721.8% |
| Total Liabilities & Equity | 13,973 | — | — |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 372 | 405 | -8.1% |
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | 49 | 30 | +63.3% |
| Stock-Based Compensation | 124 | 87 | +42.5% |
| Disposal Group Including Discontinued Operation Transaction Costs | -86 | — | — |
| Deferred Income Taxes | -47 | -93 | +49.5% |
| Change in Accounts Receivable | 36 | 14 | +157.1% |
| Increase Decrease In Due From Related Parties | 37 | 200 | -81.5% |
| Change in Inventory | -134 | -99 | -35.4% |
| Change in Accounts Payable | 74 | 200 | -63.0% |
| Increase Decrease In Due To Related Parties | 18 | -321 | +105.6% |
| Increase Decrease In Accrued Salaries | -9 | 53 | -117.0% |
| Other Operating Activities Cash Flow Statement | -135 | 42 | -421.4% |
| Net Cash from Operations | 274 | 966 | -71.6% |
| Investing Activities | |||
| Capital Expenditures | -316 | -253 | -24.9% |
| Proceeds From Divestiture Of Businesses | 3,870 | — | — |
| Other Investing Activities | -12 | — | — |
| Net Cash from Investing | 3,542 | -253 | +1500.0% |
| Financing Activities | |||
| Debt Repayments | -2,970 | -200 | -1385.0% |
| Payments For Proceeds From Parent | -21 | -8,247 | +99.7% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | -21 | -8,247 | +99.7% |
| Proceeds From Payments For Other Financing Activities | 49 | 8 | +512.5% |
| Net Cash from Financing | -2,942 | -136 | -2063.2% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 6 | 1 | +500.0% |
| Net Change in Cash | 880 | 578 | +52.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,642 | 772 | +112.7% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.